Home> Products> type 2 diabetes management medications

{ "products": [ { "_id": "6890aa548a215c65672372e1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EMPATECH LINA 25/5", "description": "EMPATECH LINA 25/5 is a pharmaceutical tablet containing a combination of two active ingredients: Empagliflozin 25MG and Linagliptin 5MG. This medication is designed to help manage blood sugar levels in adults with type 2 diabetes mellitus. The combination works through complementary mechanisms to improve glycemic control more effectively than either drug alone. Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that promotes the excretion of excess glucose through urine, while Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and suppresses glucagon release, particularly after meals. EMPATECH LINA 25/5 is generally prescribed alongside a balanced diet and regular exercise to optimize blood sugar management and reduce the risk of diabetes-related complications such as kidney damage, neuropathy, and cardiovascular issues.\n\nWhat is EMPATECH LINA 25/5?\n\nEMPATECH LINA 25/5 is a prescription medication combining Empagliflozin (25MG) and Linagliptin (5MG) tablets used to manage type 2 diabetes. It helps control elevated blood sugar levels by using dual actions — the removal of glucose via kidneys and improving pancreatic hormone responses. This combination aims to achieve better and sustained glycemic control, often necessary for patients who have inadequate blood sugar control with other treatments.\n\nUses of EMPATECH LINA 25/5\n\nTo improve blood sugar control in adults with type 2 diabetes, particularly when monotherapy is insufficient.\n\nOften used as a second-line therapy after metformin or when metformin is not tolerated.\n\nTo reduce HbA1c (hemoglobin A1c), an important measure of long-term glucose control.\n\nMay help reduce weight and blood pressure as empagliflozin aids in glucose excretion.\n\nSupports comprehensive diabetes management along with diet and exercise.\n\nPrevents or reduces the risk of diabetes-associated complications such as kidney disease, cardiovascular events, and nerve damage.\n\nSide Effects of EMPATECH LINA 25/5\n\nCommon side effects may include urinary tract infections and genital infections due to increased glucose in urine.\n\nIncreased urination and dehydration.\n\nDizziness or lightheadedness, especially when standing up quickly.\n\nHypoglycemia (low blood sugar), though rare with this combination.\n\nGastrointestinal symptoms such as nausea or diarrhea.\n\nPotential increased risk of ketoacidosis (a serious condition related to high blood acids) in rare cases.\n\nAllergic reactions, although uncommon, may occur and require prompt medical attention.\n\nPrecautions Before Using EMPATECH LINA 25/5\n\nInform your healthcare provider if you have kidney disease, liver problems, or a history of urinary tract infections.\n\nNot recommended for type 1 diabetes or diabetic ketoacidosis treatment.\n\nUse with caution if you are pregnant, planning to become pregnant, or breastfeeding.\n\nStay hydrated while on this medication to reduce the risk of dehydration and dizziness.\n\nInform your doctor about any history of pancreatitis or pancreas disorders.\n\nRegular monitoring of kidney function and blood sugar levels is advised during treatment.\n\nAvoid drinking excessive alcohol as it may increase side effects or risk of ketoacidosis.\n\nDrug Interactions: What Drugs Interact with EMPATECH LINA 25/5?\n\nOther antidiabetic medications, such as insulin or sulfonylureas, may increase the risk of hypoglycemia.\n\nDiuretics, blood pressure medications, and lithium may interact and increase side effects.\n\nDrugs that impair kidney function can affect empagliflozin’s efficacy and safety.\n\nCertain enzyme-inducing drugs may reduce linagliptin levels, lowering its effectiveness.\n\nConsult your healthcare provider for a full list of possible interactions and before starting any new medication, including over-the-counter drugs or supplements.\n\nConclusion\n\nEMPATECH LINA 25/5, containing Empagliflozin 25MG and Linagliptin 5MG, is an effective combination medication to treat high blood sugar levels caused by type 2 diabetes. Its dual-action approach targets different physiological mechanisms to improve blood glucose control, helping reduce the risks and complications associated with diabetes. While it is generally well-tolerated, awareness of possible side effects and drug interactions is important. Always use under medical supervision, alongside lifestyle modifications such as diet and exercise, for optimal diabetes management.", "price": 345.0, "discountamount": 104.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2154, "imageuri": "https://productimages.withfloats.com/actual/6890aa58dd0bc098c3220f4c.png", "tileimageuri": "https://productimages.withfloats.com/tile/6890aa58dd0bc098c3220f4c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-04T12:40:52.619Z", "updatedon": "2025-08-04T12:40:52.619Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empatech-lina-25-5/2154", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin and Linagliptin Tablets", "category": "DIABETIC RANGE", "tags": [ "Empagliflozin and Linagliptin Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67a35e1c4d6823e26538d21d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin (12.5mg), Metformin Hydrochloride (500mg)", "description": "GLIEMPAFLOZIN MET 12.5mg/500mg is a powerful combination medication formulated to manage type 2 diabetes mellitus (T2DM) effectively. It contains Empagliflozin (12.5mg) and Metformin Hydrochloride (500mg), two potent anti-diabetic agents that work synergistically to regulate blood sugar levels. This medication helps in improving glycemic control while reducing the risk of diabetes-related complications. It is prescribed as an adjunct to diet and exercise to enhance blood glucose regulation in adults with type 2 diabetes.\n\n \nKey Benefits:\n \n\n Effective Blood Sugar Control: Helps in lowering HbA1c levels, leading to better long-term glucose management.\nPromotes Weight Loss: Empagliflozin assists in weight reduction by eliminating excess glucose through urination.\nReduces Cardiovascular Risk: Beneficial for patients with heart-related complications linked to diabetes.\nImproves Insulin Sensitivity: Metformin enhances insulin action, reducing insulin resistance.\nPrevents Kidney Damage: Helps in reducing the burden on kidneys by decreasing glucose reabsorption.\nConvenient Combination Therapy: Eliminates the need for multiple medications by combining two effective drugs in one tablet.\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN MET 12.5mg/500mg works through a dual mechanism:\n\nEmpagliflozin blocks SGLT2 in the kidneys, preventing glucose reabsorption and promoting its excretion through urine. This leads to a significant reduction in blood sugar levels.\n\nMetformin lowers hepatic glucose production, decreases intestinal glucose absorption, and enhances insulin sensitivity, ensuring better blood glucose utilization by the body.\n\n \nDirections for Use:\n \n\nTake one tablet daily or as directed by your healthcare provider.\n\nSwallow the tablet whole with a glass of water. Do not crush or chew it.\n\nIt is recommended to take the medication with food to minimize gastrointestinal side effects.\n\nFollow a balanced diet and regular exercise regimen for optimal results.\n\nMonitor blood sugar levels regularly to ensure proper dosage adjustments.\n\n \nSide Effects:\n \n\nAlthough GLIEMPAFLOZIN MET 12.5mg/500mg is well tolerated, some patients may experience mild to moderate side effects, including:\n\nFrequent Urination due to glucose excretion\n\nDehydration or thirst\n\nHypoglycemia (Low Blood Sugar) when used with other anti-diabetic medications\n\nGastrointestinal Issues such as nausea, diarrhea, or stomach discomfort\n\nUrinary Tract Infections (UTIs) due to increased glucose in urine\n\nLactic Acidosis (Rare but Serious) in some cases due to Metformin", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "tablet daily", "balanced diet", "medication helps", "nausea diarrhea", "experience mild", "body directions", "significant reduction", "effective drugs", "multiple medications", "weight reduction", "work synergistically", "empagliflozin 125mg", "cases due", "diabetesrelated complications", "increased glucose", "glucose excretion dehydration", "regular exercise regimen", "metformin hydrochloride 500mg", "frequent urination due", "heartrelated complications linked", "blood glucose utilization", "eliminating excess glucose", "moderate side effects", "gliempaflozin met 125mg500mg", "healthcare provider swallow", "improving glycemic control", "potent antidiabetic agents" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2050, "imageuri": "https://productimages.withfloats.com/actual/67a35e57b167fbeb7927d316.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a35e57b167fbeb7927d316.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:48:28.684Z", "updatedon": "2025-03-17T11:04:23.276Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-12-5mg-metformin-hydrochloride-500mg-/2050", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN MET 12.5mg/ 500mg", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 12.5 mg+metformin 500 mg", "empagliflozin/metformin 5 mg/1000 mg", "Empagliflozin 12.5 mg brands in India", "empagliflozin 12.5 mg+metformin 500 mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e8611b9f7300708fe1240", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIOGLIMITERIS 1/0.2 ", "description": "TRIOGLIMITERIS 1/0.2 \nVoglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg\nIntroduction\n\nTRIOGLIMITERIS 1/0.2 is a combination medication containing Voglibose, Glimepiride, and Metformin Hydrochloride. It is primarily used in the management of type 2 diabetes mellitus to improve glycemic control through different mechanisms of action targeting glucose metabolism.\n\nComposition\n\nVoglibose (0.2 mg): An alpha-glucosidase inhibitor that delays the digestion of carbohydrates in the intestine, thereby reducing postprandial blood glucose levels.\nGlimepiride (1 mg): A sulfonylurea derivative that stimulates insulin release from pancreatic beta cells, enhancing glucose uptake in peripheral tissues.\nMetformin Hydrochloride (500 mg): A biguanide that decreases hepatic glucose production, improves insulin sensitivity in peripheral tissues, and reduces intestinal glucose absorption.\nMechanism of Action\n\nTRIOGLIMITERIS 1/0.2 combines the actions of its components to achieve optimal glycemic control:\n\nVoglibose: Inhibits alpha-glucosidase enzymes in the intestine, delaying carbohydrate digestion and reducing the absorption of glucose after meals.\nGlimepiride: Stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner, thereby lowering blood glucose levels.\nMetformin Hydrochloride: Decreases hepatic glucose production through suppression of gluconeogenesis and enhances peripheral glucose uptake and utilization by improving insulin sensitivity.\nIndications\n\nTRIOGLIMITERIS 1/0.2 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults when diet, exercise, and monotherapy with metformin or sulfonylureas alone are not sufficient.\nDosage and Administration\n\nThe typical dosage of TRIOGLIMITERIS 1/0.2 is one tablet taken orally with meals, usually once or twice daily.\nDosage adjustments may be required based on individual patient response, blood glucose levels, and renal function.\nIt is essential to adhere to the prescribed dosage regimen to achieve optimal therapeutic outcomes.\nSide Effects\n\nCommon side effects of TRIOGLIMITERIS 1/0.2 may include:\n\nHypoglycemia (especially when used in combination with insulin or other antidiabetic medications)\nGastrointestinal disturbances (such as nausea, vomiting, diarrhea, or abdominal discomfort)\nWeight gain (mainly associated with sulfonylureas)\nMore severe side effects can include:\n\nAllergic reactions (rash, itching, swelling)\nLactic acidosis (rare but serious adverse effect associated with metformin use)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with renal impairment, hepatic dysfunction, or other significant medical conditions that may affect drug metabolism or excretion.\nRegular monitoring of blood glucose levels, renal function, and liver function is recommended during treatment with TRIOGLIMITERIS 1/0.2.\nAvoid use in patients with type 1 diabetes mellitus or diabetic ketoacidosis.\nDrug Interactions\n\nTRIOGLIMITERIS 1/0.2 may interact with other medications affecting blood glucose levels, such as insulin, other oral antidiabetic agents, or drugs that affect renal function or hepatic metabolism. Close monitoring and dose adjustments may be necessary.\nConclusion\n\nTRIOGLIMITERIS 1/0.2 provides a comprehensive approach to managing type 2 diabetes mellitus by combining Voglibose, Glimepiride, and Metformin Hydrochloride. This combination targets different aspects of glucose metabolism, enhancing insulin secretion, reducing hepatic glucose production, and delaying carbohydrate absorption in the intestine. Proper dosage, administration, and monitoring for side effects are essential to achieve and maintain optimal glycemic control in diabetic patients using TRIOGLIMITERIS 1/0.2. Consultation with a healthcare provider is recommended for personalized treatment plans and management of diabetes with this medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 195.0, "discountamount": 58.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "500 mg", "0.2 mg", "one tablet", "Weight gain", "Glimepiride 1", "metformin use", "Proper dosage", "Glimepiride (1", "dosage regimen", "typical dosage", "renal function", "insulin release", "drug metabolism", "Lactic acidosis", "Close monitoring", "dose adjustments", "renal impairment", "diabetic patients", "insulin secretion", "different aspects", "Drug Interactions", "other medications", "Regular monitoring", "Dosage adjustments", "Allergic reactions", "peripheral tissues", "hepatic metabolism", "glucose metabolism", "insulin sensitivity", "healthcare provider", "Hepatic dysfunction", "Common side effects", "abdominal discomfort", "different mechanisms", "liver function tests", "diabetic ketoacidosis", "pancreatic beta cells", "combination medication", "carbohydrate digestion", "comprehensive approach", "serious adverse effect", "Metformin Hydrochloride", "carbohydrate absorption", "sulfonylurea derivative", "glucose-dependent manner", "optimal glycemic control", "type 1 diabetes mellitus", "type 2 diabetes mellitus", "More severe side effects", "alpha-glucosidase enzymes", "peripheral glucose uptake", "hepatic glucose production", "alpha-glucosidase inhibitor", "individual patient response", "personalized treatment plans", "optimal therapeutic outcomes", "Gastrointestinal disturbances", "intestinal glucose absorption", "other antidiabetic medications", "other oral antidiabetic agents", "postprandial blood glucose levels", "other significant medical conditions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1939, "imageuri": "https://productimages.withfloats.com/actual/668e86143a68154e11e7d822.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e86143a68154e11e7d822.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T13:01:05.875Z", "updatedon": "2024-07-10T13:01:05.875Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trioglimiteris-1-0-2-/1939", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIOGLIMITERIS 1/0.2 ", "category": "DIABETIC RANGE", "tags": [ "glimepiride 1mg+metformin 500mg+voglibose 0.2 mg", "Glimepiride 2mg Metformin 500mg Voglibose 0.2 mg b", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg", "voglibose glimepiride & metformin hydrochloride (s", "voglibose glimepiride + metformin hydrochloride us", "glimepiride 1mg+metformin 500mg+voglibose 0.3 mg", "glimepiride 2mg+metformin 500mg+voglibose 0.2 mg g", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668d1f7b6be1220f389cf9a3", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "THYRORISE 200 ", "description": "THYRORISE 200 \nThyroxine Sodium (200mcg)\nOverview\nTHYRORISE 200 is a pharmaceutical formulation containing Thyroxine Sodium, a synthetic form of the thyroid hormone thyroxine (T4), at a dosage of 200 mcg. Thyroxine is crucial for regulating metabolism, energy production, and overall endocrine health. THYRORISE 200 is prescribed for individuals with hypothyroidism, a condition where the thyroid gland does not produce enough hormones, leading to symptoms such as fatigue, weight gain, and depression.\n\nBenefits of Thyroxine Sodium\n\nRegulation of Metabolism\n\nThyroxine plays a vital role in regulating the body's metabolic rate.\nIt helps convert food into energy, supporting weight management and energy levels.\nSupport for Cardiovascular Health\n\nProper levels of thyroxine ensure the normal function of the heart.\nIt helps maintain healthy heart rate and blood pressure, reducing the risk of cardiovascular diseases.\nEnhancement of Cognitive Function\n\nAdequate thyroxine levels are essential for brain development and function.\nIt improves cognitive abilities, memory, and concentration, preventing cognitive decline.\nMood Stabilization\n\nThyroxine helps regulate mood and emotional well-being.\nIt can alleviate symptoms of depression and anxiety associated with hypothyroidism.\nHealthy Growth and Development\n\nCrucial for normal growth and development in children.\nEnsures proper development of bones, muscles, and the nervous system.\nUsage and Dosage\nTHYRORISE 200 should be taken as prescribed by a healthcare professional. The typical starting dose for adults with hypothyroidism is individualized based on the patient's age, weight, cardiovascular status, and other health conditions. It is usually taken once daily on an empty stomach, preferably 30 minutes to an hour before breakfast to enhance absorption.\n\nIndications for Use\n\nHypothyroidism: Effective in treating primary, secondary, and tertiary hypothyroidism.\nGoiter: Helps reduce the size of an enlarged thyroid gland.\nThyroid Cancer: Used as part of the treatment regimen for certain types of thyroid cancer.\nThyroid Hormone Replacement: For patients with thyroidectomy or radioactive iodine therapy.\nSide Effects\nWhile THYRORISE 200 is generally well-tolerated, some individuals may experience side effects, especially if the dosage is not properly adjusted. Possible side effects include:\n\nCardiovascular Issues: Palpitations, increased heart rate, and hypertension.\nNervous System Effects: Nervousness, irritability, and tremors.\nGastrointestinal Symptoms: Diarrhea, weight loss, and increased appetite.\nOthers: Hair loss, muscle weakness, and menstrual irregularities.\nPrecautions and Contraindications\n\nCardiovascular Conditions: Patients with heart disease or hypertension should use THYRORISE 200 with caution and under close medical supervision.\nDiabetes: Thyroxine can affect blood sugar levels; diabetic patients may need adjustments to their diabetes medication.\nPregnancy and Lactation: Adequate thyroxine levels are crucial during pregnancy; however, dosage adjustments may be necessary. Consult a healthcare provider.\nDrug Interactions: Thyroxine can interact with various medications, including anticoagulants, insulin, and certain antidepressants. Inform your healthcare provider of all medications you are taking.\nConclusion\nTHYRORISE 200 provides an effective solution for individuals with hypothyroidism and related conditions. By supplementing the body's thyroxine levels, it helps restore normal metabolic function, enhances cardiovascular and cognitive health, and improves overall well-being. Under the guidance of a healthcare professional, THYRORISE 200 can significantly improve the quality of life for those suffering from thyroid hormone deficiencies.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 260.0, "discountamount": 78.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Hair loss", "vital role", "weight loss", "weight gain", "heart disease", "empty stomach", "energy levels", "normal growth", "Proper levels", "synthetic form", "Thyroid Cancer", "Healthy Growth", "blood pressure", "metabolic rate", "muscle weakness", "enough hormones", "normal function", "Thyroxine Sodium", "cognitive health", "diabetic patients", "brain development", "energy production", "weight management", "Drug Interactions", "treatment regimen", "cognitive decline", "dosage adjustments", "proper development", "Mood Stabilization", "effective solution", "Cognitive Function", "related conditions", "overall well-being", "healthy heart rate", "blood sugar levels", "various medications", "diabetes medication", "healthcare provider", "cognitive abilities", "emotional well-being", "Cardiovascular Issues", "cardiovascular status", "Cardiovascular Health", "Possible side effects", "typical starting dose", "Nervous System Effects", "enlarged thyroid gland", "tertiary hypothyroidism", "cardiovascular diseases", "healthcare professional", "other health conditions", "menstrual irregularities", "overall endocrine health", "Gastrointestinal Symptoms", "Cardiovascular Conditions", "normal metabolic function", "Adequate thyroxine levels", "close medical supervision", "pharmaceutical formulation", "radioactive iodine therapy", "Thyroid Hormone Replacement", "thyroid hormone deficiencies" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1920, "imageuri": "https://productimages.withfloats.com/actual/668d1fa94944b8c562115315.png", "tileimageuri": "https://productimages.withfloats.com/tile/668d1fa94944b8c562115315.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-09T11:31:07.271Z", "updatedon": "2024-07-09T11:31:07.271Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/thyrorise-200-/1920", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "THYRORISE 200 ", "category": "DIABETICSRANGE", "tags": [ "Thyroxine 200 mg side effects", "is 200 mcg of levothyroxine, a high dose", "Thyroxine 200 mg uses", "Thyrox 200 mg", "Thyronorm 200 mcg uses", "Thyroxine Sodium Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661ad3166170d1ff8cb4574", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD PIO 20/15 ", "description": "TENELIGOLD PIO 20/15 \nTeneligliptin & Pioglitazone\nTENELIGOLD PIO 20/15 is a combination medication that contains Teneligliptin and Pioglitazone. It is primarily used in the management of type 2 diabetes mellitus, a condition characterized by high blood sugar levels due to insulin resistance or inadequate insulin production.\n\nTeneligliptin: Teneligliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the DPP-4 enzyme, which in turn enhances the levels of incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones stimulate insulin secretion and inhibit glucagon release, leading to improved glucose control after meals.\n\nPioglitazone: Pioglitazone belongs to the thiazolidinedione class of medications. It works by improving insulin sensitivity in muscle and adipose (fat) tissues, reducing glucose production in the liver, and enhancing glucose uptake in peripheral tissues. This helps lower blood sugar levels and improves overall glycemic control.\n\nBenefits of TENELIGOLD PIO 20/15:\nComprehensive Glycemic Control: The combination of Teneligliptin and Pioglitazone addresses different aspects of glucose metabolism, providing comprehensive control over fasting and postprandial (after-meal) blood sugar levels.\n\nEnhanced Insulin Sensitivity: Pioglitazone improves insulin sensitivity in cells, allowing better utilization of glucose and reducing insulin resistance.\n\nIncretin Hormone Enhancement: Teneligliptin enhances the action of incretin hormones, which regulate insulin secretion and glucagon levels, leading to better glucose regulation after meals.\n\nCardioprotective Effects: Pioglitazone has been associated with cardiovascular benefits such as improved lipid profiles and reduced risk of cardiovascular events in some patients.\n\nHow to Use TENELIGOLD PIO 20/15:\nDosage: The typical dosage is one tablet taken orally once daily, usually with meals. Your healthcare provider will determine the appropriate dosage based on your medical condition and response to treatment.\n\nAdministration: Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless advised by your doctor.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/teneligold-pio-20-15-134077", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "risk", "turn", "Order", "EMAIL", "GLP-1", "water", "glass", "meals", "cells", "liver", "action", "muscle", "doctor", "adipose", "fasting", "patients", "response", "treatment", "one tablet", "management", "information", "medications", "utilization", "Pioglitazone", "postprandial", "fat) tissues", "DPP-4 enzyme", "sterispharma", "sterisonline", "CALL/WHATSAPP", "Teneligliptin", "teneligold-pio", "glucose uptake", "lipid profiles", "typical dosage", "Administration", "TENELIGOLD PIO", "glucagon levels", "glucose control", "glucagon release", "DPP-4) inhibitor", "incretin hormones", "medical condition", "different aspects", "insulin secretion", "glucose production", "insulin resistance", "appropriate dosage", "glucose metabolism", "glucose regulation", "peripheral tissues", "healthcare provider", "cardiovascular events", "comprehensive control", "combination medication", "dipeptidyl peptidase-4", "thiazolidinedione class", "cardiovascular benefits", "high blood sugar levels", "Cardioprotective Effects", "overall glycemic control", "type 2 diabetes mellitus", "meal) blood sugar levels", "Enhanced Insulin Sensitivity", "Incretin Hormone Enhancement", "inadequate insulin production", "Comprehensive Glycemic Control", "glucose-dependent insulinotropic peptide" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1480, "imageuri": "https://productimages.withfloats.com/actual/6661ad34c749b7962dbc4345.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661ad34c749b7962dbc4345.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:36:01.592Z", "updatedon": "2024-06-28T12:39:29.014Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/teneligold-pio-20-15-/1480", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PIO 20/15 ", "category": "DIABETIC RANGE", "tags": [ "TENELIGOLD PIO 20/15", "Teneligliptin", "Pioglitazone", "Teneligliptin uses", "Teneligliptin side effects", "Teneligliptin 20mg", "Teneligliptin+Metformin", "Teneligliptin 20 mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661a4c8870e7b20c49e5b6e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD 20 ", "description": "TENELIGOLD 20 \nTeneligliptin (20mg)\nIntroduction to TENELIGOLD 20\nTENELIGOLD 20 contains Teneligliptin 20mg, a medication primarily used for the management of type 2 diabetes mellitus. Teneligliptin belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors, which help control blood sugar levels by enhancing the body's own ability to regulate insulin after meals. This medication is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nWhat is Teneligliptin?\nOverview of Teneligliptin\nTeneligliptin is an oral diabetes medication that helps increase insulin production and decrease glucose production in the liver. It works by inhibiting the DPP-4 enzyme, which results in prolonged activity of incretin hormones. These hormones play a significant role in regulating glucose metabolism.\n\nMechanism of Action\nIncretin Hormones: Teneligliptin enhances the levels of incretin hormones, which increase insulin synthesis and release from pancreatic beta cells in response to meals.\nGlucose Regulation: It reduces the liver’s production of glucose, especially after meals, thereby helping to lower blood sugar levels.\nReduced Blood Sugar Spikes: By increasing insulin release and decreasing glucagon levels, Teneligliptin helps control blood sugar spikes after meals.\nBenefits of TENELIGOLD 20\nEffective Blood Sugar Management\nPostprandial Glucose Control: TENELIGOLD 20 helps manage postprandial (after-meal) blood sugar levels by enhancing the body’s natural response to meals.\nFasting Blood Sugar Control: It also helps in lowering fasting blood sugar levels, providing a balanced glycemic control throughout the day.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: TENELIGOLD 20 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nCombination Therapy: It can be used alone or in combination with other antidiabetic medications such as metformin, sulfonylureas, or insulin for enhanced glycemic control.\nAdditional Health Benefits\nWeight Neutral: Teneligliptin is generally weight neutral, making it a favorable option for patients concerned about weight gain associated with other diabetes medications.\nLow Risk of Hypoglycemia: When used alone, Teneligliptin has a low risk of causing hypoglycemia compared to some other diabetes medications.\nHow to Use TENELIGOLD 20\nDosage and Administration\nRecommended Dosage: The typical dosage of TENELIGOLD 20 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take TENELIGOLD 20 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/teneligold-20-133447", "price": 165.0, "discountamount": 49.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "diet", "food", "body", "water", "drugs", "class", "EMAIL", "meals", "Order", "liver", "adults", "Action", "option", "ability", "Support", "Overview", "Low Risk", "readings", "patients", "metformin", "Mechanism", "same time", "TENELIGOLD", "full glass", "one tablet", "Guidelines", "information", "weight gain", "Optimal Use", "Adjustments", "Hypoglycemia", "sterispharma", "Introduction", "sterisonline", "best results", "DPP-4 enzyme", "sulfonylureas", "CALL/WHATSAPP", "Administration", "treatment plan", "typical dosage", "Consistent Use", "Weight Neutral", "glucagon levels", "insulin release", "natural response", "Exercise Adjunct", "significant role", "excellent adjunct", "insulin synthesis", "incretin hormones", "Recommended Dosage", "insulin production", "glucose production", "Glucose Regulation", "glucose metabolism", "prolonged activity", "Teneligliptin 20mg", "Combination Therapy", "individual response", "healthcare provider", "Diabetes Management", "Blood Sugar Control", "pancreatic beta cells", "lifestyle modifications", "meal) blood sugar levels", "type 2 diabetes mellitus", "oral diabetes medication", "enhanced glycemic control", "balanced glycemic control", "Additional Health Benefits", "Reduced Blood Sugar Spikes", "other diabetes medications", "Postprandial Glucose Control", "other antidiabetic medications", "Effective Blood Sugar Management", "dipeptidyl peptidase-4 (DPP-4) inhibitors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1471, "imageuri": "https://productimages.withfloats.com/actual/6661a4ca0c19ea48b9490a9f.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661a4ca0c19ea48b9490a9f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:00:08.3Z", "updatedon": "2024-06-29T05:31:45.493Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/teneligold-20-/1471", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD 20 ", "category": "DIABETIC RANGE", "tags": [ "TENELIGOLD 20", "Teneligliptin (20mg)", "Teneligliptin Tablets 20 mg uses", "Teneligliptin 20 mg price", "Teneligliptin 20 mg side effects", "Teneligliptin 20 mg uses in Hindi", "Teneligliptin+Metformin" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66604fa8870e7b20c49e43ef", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LINALIGLIP 2.5/500 ", "description": "LINALIGLIP 2.5/500 \nLinagliptin & Metformin Hydrochloride\nIntroduction to LINALIGLIP 2.5/500\nLINALIGLIP 2.5/500 is a combination medication that includes Linagliptin 2.5mg and Metformin Hydrochloride 500mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Linagliptin and Metformin, LINALIGLIP 2.5/500 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Linagliptin and Metformin?\nOverview of Linagliptin\nLinagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that helps regulate blood glucose levels by increasing insulin release and decreasing glucagon levels in response to meals. By enhancing incretin hormones, Linagliptin aids in maintaining better overall blood sugar control throughout the day.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization.\n\nBenefits of LINALIGLIP 2.5/500\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Linagliptin helps regulate postprandial (after-meal) glucose levels, while Metformin assists in lowering fasting glucose levels by promoting insulin sensitivity and reducing hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: LINALIGLIP 2.5/500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, LINALIGLIP 2.5/500 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nConvenience and Compliance\nTwice-Daily Dosing: The formulation allows for effective blood sugar control with twice-daily dosing, improving patient compliance and convenience.\nReduced Pill Burden: Combining two effective diabetes medications into one pill simplifies the treatment regimen, making it easier for patients to adhere to their prescribed therapy.\nHow to Use LINALIGLIP 2.5/500\nDosage and Administration\nRecommended Dosage: The typical dosage of LINALIGLIP 2.5/500 is one tablet taken twice daily, with meals. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take LINALIGLIP 2.5/500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/linaliglip-2-5-500-134273", "price": 255.0, "discountamount": 76.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "Diet", "water", "liver", "EMAIL", "meals", "Order", "action", "amount", "therapy", "Support", "readings", "Benefits", "Overview", "one pill", "patients", "biguanide", "one tablet", "Guidelines", "neuropathy", "full glass", "retinopathy", "Convenience", "formulation", "Adjustments", "Linagliptin", "information", "Optimal Use", "utilization", "Reduced Risk", "best results", "sterisonline", "Introduction", "Postprandial", "sterispharma", "CALL/WHATSAPP", "effectiveness", "Administration", "typical dosage", "Consistent Use", "treatment plan", "dual mechanism", "glucagon levels", "two medications", "insulin release", "Exercise Adjunct", "treatment regimen", "multiple pathways", "excellent adjunct", "incretin hormones", "patient compliance", "LINALIGLIP 2.5/500", "glucose regulation", "Twice-Daily Dosing", "Recommended Dosage", "Diabetes Management", "healthcare provider", "Reduced Pill Burden", "individual response", "insulin sensitivity", "meal) glucose levels", "blood glucose levels", "cardiovascular disease", "combination medication", "long-term complications", "lifestyle modifications", "Metformin Hydrochloride", "Fasting Glucose Control", "complementary mechanisms", "type 2 diabetes mellitus", "stable blood sugar levels", "peripheral glucose uptake", "hepatic glucose production", "gastrointestinal discomfort", "overall blood sugar control", "effective blood sugar control", "comprehensive glycemic control", "Effective Blood Sugar Management", "dipeptidyl peptidase-4) inhibitor", "two effective diabetes medications", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1382, "imageuri": "https://productimages.withfloats.com/actual/66604fab4f159c14e162bd89.png", "tileimageuri": "https://productimages.withfloats.com/tile/66604fab4f159c14e162bd89.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:44:40.743Z", "updatedon": "2024-06-29T11:20:20.557Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/linaliglip-2-5-500-/1382", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGLIP 2.5/500 ", "category": "DIABETIC RANGE", "tags": [ "LINALIGLIP 2.5/500", "Linagliptin", "Metformin Hydrochloride", "Metformin hydrochloride uses", "Metformin hydrochloride side effects", "Metformin hydrochloride used for", "metformin hydrochloride dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66604a47870e7b20c49e422b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LINALIGLIP 2.5 ", "description": "LINALIGLIP 2.5 \nLinagliptin 2.5 mg\nIntroduction to LINALIGLIP 2.5\nLINALIGLIP 2.5 contains Linagliptin 2.5mg, a medication used primarily for the management of type 2 diabetes mellitus. Linagliptin belongs to a class of drugs known as DPP-4 (dipeptidyl peptidase-4) inhibitors, which help improve blood sugar control by enhancing the body's natural incretin hormones. This medication is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nWhat is Linagliptin?\nOverview of Linagliptin\nLinagliptin is a DPP-4 inhibitor that helps regulate blood glucose levels by increasing insulin release and decreasing glucagon levels in response to meals. By enhancing incretin hormones, Linagliptin aids in maintaining better overall blood sugar control throughout the day.\n\nMechanism of Action\nDPP-4 Inhibition: Linagliptin works by inhibiting the enzyme DPP-4, which breaks down incretin hormones. By inhibiting this enzyme, Linagliptin increases the levels of incretin hormones, which stimulate insulin release and decrease glucagon production in response to meals.\nEnhanced Insulin Response: The increased insulin release helps lower postprandial (after-meal) blood sugar levels, while decreased glucagon levels reduce hepatic glucose production, contributing to overall blood sugar control.\nBenefits of LINALIGLIP 2.5\nEffective Blood Sugar Management\nPostprandial Glucose Control: LINALIGLIP 2.5 helps reduce blood sugar spikes after meals by enhancing the body's natural insulin response.\nOverall Glycemic Control: By increasing incretin hormones, Linagliptin helps maintain stable blood glucose levels throughout the day, providing comprehensive glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: LINALIGLIP 2.5 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, LINALIGLIP 2.5 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nConvenience and Compliance\nOnce-Daily Dosing: LINALIGLIP 2.5 is taken once daily, making it convenient for patients to incorporate into their daily routine.\nComplementary Therapy: Linagliptin can be used as monotherapy or in combination with other antidiabetic medications for a more comprehensive diabetes management plan.\nHow to Use LINALIGLIP 2.5\nDosage and Administration\nRecommended Dosage: The typical dosage of LINALIGLIP 2.5 is one 2.5mg tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. It is important to take the medication at the same time each day to maintain consistent blood levels.\nGuidelines for Optimal Use\nConsistent Use: For best results, take LINALIGLIP 2.5 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/linaliglip-2-5-134280", "price": 205.0, "discountamount": 61.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "diet", "food", "Order", "class", "EMAIL", "drugs", "water", "meals", "adults", "Dosing", "Action", "enzyme", "Support", "Overview", "Benefits", "patients", "readings", "Mechanism", "same time", "LINALIGLIP", "neuropathy", "Compliance", "full glass", "Guidelines", "Optimal Use", "information", "combination", "monotherapy", "Convenience", "retinopathy", "Adjustments", "sterispharma", "Introduction", "Reduced Risk", "sterisonline", "best results", "daily routine", "CALL/WHATSAPP", "Administration", "typical dosage", "treatment plan", "Consistent Use", "glucagon levels", "insulin release", "DPP-4 inhibitor", "one 2.5mg tablet", "DPP-4 Inhibition", "Exercise Adjunct", "excellent adjunct", "Linagliptin 2.5mg", "blood sugar spikes", "Recommended Dosage", "healthcare provider", "glucagon production", "individual response", "Complementary Therapy", "cardiovascular disease", "lifestyle modifications", "long-term complications", "consistent blood levels", "Overall Glycemic Control", "natural insulin response", "type 2 diabetes mellitus", "meal) blood sugar levels", "natural incretin hormones", "stable blood sugar levels", "Enhanced Insulin Response", "hepatic glucose production", "stable blood glucose levels", "overall blood sugar control", "Postprandial Glucose Control", "other antidiabetic medications", "comprehensive glycemic control", "Effective Blood Sugar Management", "dipeptidyl peptidase-4) inhibitors", "comprehensive diabetes management plan" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1376, "imageuri": "https://productimages.withfloats.com/actual/66604a496030c166b1a78a3e.png", "tileimageuri": "https://productimages.withfloats.com/tile/66604a496030c166b1a78a3e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:21:43.142Z", "updatedon": "2024-06-29T12:00:41.066Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//linaliglip-2-5-/1376", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGLIP 2.5 ", "category": "DIABETIC RANGE", "tags": [ "LINALIGLIP 2.5", "Linagliptin 2.5 mg", "Linagliptin 2.5 mg uses", "Linagliptin 2.5 mg side effects", "Linagliptin 2.5 mg price", "Linagliptin 2.5 mg price in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666038658e599e12c0ea92f9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLISAXAPIN M 2.5/500 ", "description": "GLISAXAPIN M 2.5/500 \nSaxagliptin (2.5mg), Metformin HCI (ER) (500mg)\nIntroduction to GLISAXAPIN M 2.5/500\nGLISAXAPIN M 2.5/500 is a combination medication containing Saxagliptin 2.5mg and Metformin HCl (Extended Release) 500mg. This medication is used primarily for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Saxagliptin and Metformin, GLISAXAPIN M 2.5/500 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Saxagliptin and Metformin?\nOverview of Saxagliptin\nSaxagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that enhances the body's natural incretin hormones, which help regulate blood glucose by increasing insulin release and decreasing glucagon levels in response to meals.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The extended-release formulation ensures a prolonged effect throughout the day.\n\nBenefits of GLISAXAPIN M 2.5/500\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Saxagliptin helps regulate postprandial (after-meal) glucose levels, while Metformin assists in lowering fasting glucose levels by promoting insulin sensitivity and reducing hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: GLISAXAPIN M 2.5/500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, this combination medication can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nConvenience and Compliance\nOnce-Daily Dosing: The extended-release formulation of Metformin allows for once-daily dosing, improving patient compliance and convenience.\nReduced Pill Burden: Combining two effective diabetes medications into one pill simplifies the treatment regimen, making it easier for patients to adhere to their prescribed therapy.\nHow to Use GLISAXAPIN M 2.5/500\nDosage and Administration\nRecommended Dosage: The typical dosage of GLISAXAPIN M 2.5/500 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take GLISAXAPIN M 2.5/500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glisaxapin-m-2-5-500-133433", "price": 175.0, "discountamount": 52.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "Diet", "liver", "water", "meals", "Order", "EMAIL", "amount", "action", "Support", "patients", "Benefits", "readings", "one pill", "Overview", "biguanide", "Guidelines", "one tablet", "neuropathy", "full glass", "utilization", "Adjustments", "Convenience", "information", "retinopathy", "Optimal Use", "best results", "Reduced Risk", "Introduction", "sterisonline", "GLISAXAPIN M", "Postprandial", "sterispharma", "Daily Dosing", "Metformin HCI", "Metformin HCl", "CALL/WHATSAPP", "effectiveness", "blood glucose", "Administration", "Consistent Use", "typical dosage", "treatment plan", "dual mechanism", "insulin release", "two medications", "glucagon levels", "Exercise Adjunct", "Extended Release", "prolonged effect", "multiple pathways", "Saxagliptin 2.5mg", "excellent adjunct", "treatment regimen", "glucose regulation", "prescribed therapy", "Recommended Dosage", "patient compliance", "insulin sensitivity", "blood sugar control", "individual response", "Diabetes Management", "Reduced Pill Burden", "healthcare provider", "meal) glucose levels", "cardiovascular disease", "combination medication", "lifestyle modifications", "long-term complications", "Fasting Glucose Control", "type 2 diabetes mellitus", "complementary mechanisms", "natural incretin hormones", "stable blood sugar levels", "peripheral glucose uptake", "hepatic glucose production", "gastrointestinal discomfort", "extended-release formulation", "comprehensive glycemic control", "Effective Blood Sugar Management", "dipeptidyl peptidase-4) inhibitor", "two effective diabetes medications", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1360, "imageuri": "https://productimages.withfloats.com/actual/666038680c19ea48b945d8e1.png", "tileimageuri": "https://productimages.withfloats.com/tile/666038680c19ea48b945d8e1.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T10:05:25.723Z", "updatedon": "2024-06-29T12:34:30.073Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glisaxapin-m-2-5-500-/1360", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLISAXAPIN M 2.5/500 ", "category": "DIABETIC RANGE", "tags": [ "GLISAXAPIN M 2.5/500", "Saxagliptin (2.5mg)", "Metformin HCI (ER) (500mg)", "Metformin HCl", "Metformin 500 mg side effects", "Metformin Hydrochloride Tablets IP 500mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }